A leading obesity doctor has said a new trial of weight loss drugs Mounjaro and Wegovy may lead advertisers to reconsider their prices.

The US is the biggest market for prescription drugs, accounting for roughly $600bn of annual sales out of a global $1tn or so ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...

A bold move by US President Donald Trump to slash the cost of prescription drugs in America has sent shockwaves through the ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

PhRMA, which gave $1 million to Trump's inaugural fund, warned against parts of Trump's drug pricing executive order.

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

During a live event, Shuo Ma, MD, PhD, discussed the outcomes of the BRUIN trial of pirtobrutinib in BTK inhibitor–pretreated ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

As a Biden administration ban on so-called “junk fees” took effect Monday, Ticketmaster said it would start displaying the ...